{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:52:23Z","timestamp":1779285143941,"version":"3.51.4"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1888,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Deletion of glycine<\/jats:bold>\n                                 <jats:bold>\n                                    N\n                                 <\/jats:bold>\n                                 <jats:bold>-methyltransferase (GNMT), the main gene involved in liver<\/jats:bold>\n                                 <jats:bold>\n                                    S\n                                 <\/jats:bold>\n                                 <jats:bold>-adenosylmethionine (SAM) catabolism, leads to the hepatic accumulation of this molecule and the development of fatty liver and fibrosis in mice. To demonstrate that the excess of hepatic SAM is the main agent contributing to liver disease in<\/jats:bold>\n                                 <jats:bold>\n                                    GNMT\n                                 <\/jats:bold>\n                                 <jats:bold>knockout (KO) mice, we treated 1.5-month-old<\/jats:bold>\n                                 <jats:bold>\n                                    GNMT\n                                 <\/jats:bold>\n                                 <jats:bold>-KO mice for 6 weeks with nicotinamide (NAM), a substrate of the enzyme NAM<\/jats:bold>\n                                 <jats:bold>\n                                    N\n                                 <\/jats:bold>\n                                 <jats:bold>-methyltransferase. NAM administration markedly reduced hepatic SAM content, prevented DNA hypermethylation, and normalized the expression of critical genes involved in fatty acid metabolism, oxidative stress, inflammation, cell proliferation, and apoptosis. More importantly, NAM treatment prevented the development of fatty liver and fibrosis in<\/jats:bold>\n                                 <jats:bold>\n                                    GNMT\n                                 <\/jats:bold>\n                                 <jats:bold>-KO mice. Because<\/jats:bold>\n                                 <jats:bold>\n                                    GNMT\n                                 <\/jats:bold>\n                                 <jats:bold>expression is down-regulated in patients with cirrhosis, and because some subjects with<\/jats:bold>\n                                 <jats:bold>\n                                    GNMT\n                                 <\/jats:bold>\n                                 <jats:bold>mutations have spontaneous liver disease, the clinical implications of the present findings are obvious, at least with respect to these latter individuals. Because NAM has been used for many years to treat a broad spectrum of diseases (including pellagra and diabetes) without significant side effects, it should be considered in subjects with<\/jats:bold>\n                                 <jats:bold>\n                                    GNMT\n                                 <\/jats:bold>\n                                 <jats:bold>mutations.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>The findings of this study indicate that the anomalous accumulation of SAM in<\/jats:bold>\n                                 <jats:bold>\n                                    GNMT\n                                 <\/jats:bold>\n                                 <jats:bold>-KO mice can be corrected by NAM treatment leading to the normalization of the expression of many genes involved in fatty acid metabolism, oxidative stress, inflammation, cell proliferation, and apoptosis, as well as reversion of the appearance of the pathologic phenotype. (Hepatology 2010)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.23639","type":"journal-article","created":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T20:26:03Z","timestamp":1267475163000},"page":"105-114","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":95,"title":["Fatty Liver and Fibrosis in Glycine N -Methyltransferase Knockout Mice Is Prevented by Nicotinamide"],"prefix":"10.1097","volume":"52","author":[{"given":"Marta","family":"Varela-Rey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Mart\u00ednez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fern\u00e1ndez-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nieves","family":"Embade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego F.","family":"Calvisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aswhin","family":"Woodhoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario F.","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Julve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Rodr\u00edguez-Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itziar","family":"Frades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zigmund","family":"Luka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Esteller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly C.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz M.","family":"Mart\u00ednez-Chantar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Mato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20250312","doi-asserted-by":"crossref","first-page":"2250722511","DOI":"10.1074\/jbc.R109.019273","article-title":"Glycine Nmethyltransferase and regulation of Sadenosylmethionine levels.","volume":"284","author":"Luka","year":"2009","journal-title":"J Biol Chem"},{"key":"R2-12-20250312","doi-asserted-by":"crossref","first-page":"273293","DOI":"10.1146\/annurev.nutr.28.061807.155438","article-title":"Methionine metabolism and liver disease.","volume":"28","author":"Mato","year":"2008","journal-title":"Annu Rev Nutr"},{"key":"R3-12-20250312","doi-asserted-by":"crossref","first-page":"448464","DOI":"10.1023\/A:1010577512912","article-title":"Glycine Nmethyltransferase deficiency: a novel inborn error causing persistent isolated hypermethioninemia.","volume":"24","author":"Mudd","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"R4-12-20250312","first-page":"745759","article-title":"Glycine Nmethyltransferase deficiency: a new patient with a novel mutation.","volume":"26","author":"AugoustidesSavvopoulou","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"R5-12-20250312","doi-asserted-by":"crossref","first-page":"393397","DOI":"10.1007\/s11248-006-0008-1","article-title":"A glycine Nmethyltransferase knockout mouse model for humans with deficiency of this enzyme.","volume":"15","author":"Luka","year":"2006","journal-title":"Transgenic Res"},{"key":"R6-12-20250312","first-page":"11911199","article-title":"Loss of the glycine Nmethyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.","volume":"47","author":"MartinezChantar","year":"2008","journal-title":"Hepatology"},{"key":"R7-12-20250312","doi-asserted-by":"crossref","first-page":"816826","DOI":"10.1002\/ijc.23979","article-title":"Characterization of a glycine Nmethyltransferase gene knockout mouse model for hepatocellular carcinoma: implications of the gender disparity in liver cancer susceptibility.","volume":"124","author":"Liao","year":"2009","journal-title":"Int J Cancer"},{"key":"R8-12-20250312","doi-asserted-by":"crossref","first-page":"246247","DOI":"10.1016\/j.taap.2009.03.017","article-title":"Hepatocellular carcinoma in GNMT mice.","volume":"237","author":"Wagner","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"R9-12-20250312","doi-asserted-by":"crossref","first-page":"787793","DOI":"10.1002\/(SICI)1097-0215(19980302)75:5<787::AID-IJC20>3.0.CO;2-2","article-title":"Characterization of glycine Nmethyltransferase gene expression in human hepatocellular carcinoma.","volume":"75","author":"Chen","year":"1998","journal-title":"Int J Cancer"},{"key":"R10-12-20250312","doi-asserted-by":"crossref","first-page":"907914","DOI":"10.1016\/S0168-8278(00)80122-1","article-title":"Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma.","volume":"33","author":"Avila","year":"2000","journal-title":"J Hepatol"},{"key":"R11-12-20250312","doi-asserted-by":"crossref","first-page":"11731178","DOI":"10.1038\/nature04209","article-title":"Towards a proteomescale map of the human proteinprotein interaction network.","volume":"437","author":"Rual","year":"2005","journal-title":"Nature"},{"key":"R12-12-20250312","doi-asserted-by":"crossref","first-page":"203216","DOI":"10.1016\/S0021-9258(18)56110-X","article-title":"Methylation of nicotinamide with soluble enzyme system from rat liver.","volume":"189","author":"Cantoni","year":"1951","journal-title":"J Biol Chem"},{"key":"R13-12-20250312","doi-asserted-by":"crossref","first-page":"16771681","DOI":"10.1002\/1522-2683(200206)23:11<1677::AID-ELPS1677>3.0.CO;2-Z","article-title":"Highperformance capillary electrophoretic method for the quantification of 5methyl 2deoxycytidine in genomic DNA: application to plant, animal and human cancer tissues.","volume":"23","author":"Fraga","year":"2002","journal-title":"Electrophoresis"},{"key":"R14-12-20250312","doi-asserted-by":"crossref","first-page":"624628","DOI":"10.1006\/bbrc.1999.1187","article-title":"A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands.","volume":"262","author":"Pogribny","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"R15-12-20250312","first-page":"608617","article-title":"Evidence for an LKB1AMPKeNOS cascade regulated by HGF, Sadenosymehtionine and nitric oxide in hepatocyte proliferation.","volume":"49","author":"VazquezChantada","year":"2009","journal-title":"Hepatology"},{"key":"R16-12-20250312","first-page":"1988519890","article-title":"Lmethionine availability regulates expression of the methionine adenosyltransferase 2A gene in human hepatocarcinoma cells: role of Sadenosylmethionine.","volume":"278","author":"MartinezChantar","year":"2003","journal-title":"J Biol Chem"},{"key":"R17-12-20250312","doi-asserted-by":"crossref","first-page":"36693679","DOI":"10.4161\/cc.7.23.7164","article-title":"Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues.","volume":"7","author":"Fulco","year":"2008","journal-title":"Cell Cycle"},{"key":"R18-12-20250312","doi-asserted-by":"crossref","first-page":"13061312","DOI":"10.1002\/hep.21650","article-title":"Role of SadenosylLmethionine in liver health and injury.","volume":"45","author":"Mato","year":"2007","journal-title":"Hepatology"},{"key":"R19-12-20250312","doi-asserted-by":"crossref","first-page":"55605565","DOI":"10.1073\/pnas.091016398","article-title":"Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation.","volume":"98","author":"Lu","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-12-20250312","doi-asserted-by":"crossref","first-page":"28632871","DOI":"10.2337\/db07-0907","article-title":"Increased hepatic CD36 expression contributes to dyslipidemia associated with dietinduced obesity.","volume":"56","author":"Koonen","year":"2007","journal-title":"Diabetes"},{"key":"R21-12-20250312","doi-asserted-by":"crossref","first-page":"10631076","DOI":"10.1128\/MCB.26.3.1063-1076.2006","article-title":"Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiationrelated protein.","volume":"26","author":"Chang","year":"2006","journal-title":"Mol Cell Biol"},{"key":"R22-12-20250312","doi-asserted-by":"crossref","first-page":"16561659","DOI":"10.1126\/science.1126010","article-title":"Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity.","volume":"312","author":"Uno","year":"2006","journal-title":"Science"},{"key":"R23-12-20250312","doi-asserted-by":"crossref","first-page":"74737478","DOI":"10.1073\/pnas.96.13.7473","article-title":"A critical role for the peroxisome proliferatorsactivated receptor (PPAR) in the cellular fasting response: the PPARnull mouse as a model of fatty acids oxidation disorders.","volume":"96","author":"Leone","year":"1999","journal-title":"Proc Natl Acad USA"},{"key":"R24-12-20250312","first-page":"223232","article-title":"Dotor J, et al. Sadenosylmethionine regulates cytoplasmic HuR via AMPactivated kinase.","volume":"131","author":"MartinezChantar","year":"2006","journal-title":"Gastroenterology"},{"key":"R25-12-20250312","first-page":"608617","article-title":"Evidence for LKB1AMPactivated protein kinaseendothelial nitric oxide synthase cascade regulated by hepatocyte growth factor, Sadenosylmethionine, an nitric oxide in hepatocyte proliferation.","volume":"49","author":"VazquezChantada","year":"2009","journal-title":"Hepatology"},{"key":"R26-12-20250312","doi-asserted-by":"crossref","first-page":"97939798","DOI":"10.1073\/pnas.0802917105","article-title":"Sirt1 protects against highfat dietinduced metabolic damage.","volume":"105","author":"Pfluger","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R27-12-20250312","doi-asserted-by":"crossref","first-page":"327338","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocytespecific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.","volume":"9","author":"Purushotham","year":"2009","journal-title":"Cell Metab"},{"key":"R28-12-20250312","doi-asserted-by":"crossref","first-page":"4509945107","DOI":"10.1074\/jbc.M205670200","article-title":"Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast Sir2 and human SIRT1.","volume":"277","author":"Bitterman","year":"2002","journal-title":"J Biol Chem"},{"key":"R29-12-20250312","doi-asserted-by":"crossref","first-page":"661673","DOI":"10.1016\/j.devcel.2008.02.004","article-title":"Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPKmediated regulation of Nampt.","volume":"14","author":"Fulco","year":"2008","journal-title":"Dev Cell"},{"key":"R30-12-20250312","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.alcohol.2004.07.008","article-title":"Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.","volume":"34","author":"Lieber","year":"2004","journal-title":"Alcohol"},{"key":"R31-12-20250312","first-page":"12921294","article-title":"Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A.","volume":"16","author":"MartinezChantar","year":"2002","journal-title":"FASEB J"},{"key":"R32-12-20250312","doi-asserted-by":"crossref","first-page":"967977","DOI":"10.1016\/S0039-128X(02)00044-2","article-title":"Steroid and sterol 7hydroxylation: ancient pathways.","volume":"67","author":"Lathe","year":"2002","journal-title":"Steroids"},{"key":"R33-12-20250312","first-page":"10671075","article-title":"CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.","volume":"105","author":"Leclerq","year":"2000","journal-title":"J Clin Inv"},{"key":"R34-12-20250312","doi-asserted-by":"crossref","first-page":"10811083","DOI":"10.1016\/j.bcp.2005.01.007","article-title":"Inhibition of CYP2E1 catalytic activity in vitro by SadenosylLmethionine.","volume":"69","author":"Caro","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"R35-12-20250312","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1046\/j.1365-2249.2003.02031.x","article-title":"Nicotinamide is a potent inhibitor of proinflammatory cytokines.","volume":"131","author":"Ungerstedt","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"R36-12-20250312","doi-asserted-by":"crossref","first-page":"11171128","DOI":"10.1053\/j.gastro.2006.01.006","article-title":"Ubiquitous activation of Ras and JakStat pathways in human HCC.","volume":"130","author":"Calvisi","year":"2006","journal-title":"Gastroenterology"},{"key":"R37-12-20250312","doi-asserted-by":"crossref","first-page":"9961005","DOI":"10.1038\/cr.2009.73","article-title":"Butther et al. Lipid accumulation in hepatocytes induces fibrogenic activationnof hepatic stellate cells.","volume":"19","author":"Wobser","year":"2009","journal-title":"Cell Res"},{"key":"R38-12-20250312","doi-asserted-by":"crossref","first-page":"370379","DOI":"10.1055\/s-0028-1091981","article-title":"Mechanisms of disease progression in nonalcoholic fatty liver disease.","volume":"28","author":"Jou","year":"2008","journal-title":"Semin Liver Dis"},{"key":"R39-12-20250312","first-page":"7079","article-title":"Subclinical pellagra. Its diagnostic and treatment.","volume":"2","author":"Green","year":"1970","journal-title":"Schizophrenia"},{"key":"R40-12-20250312","doi-asserted-by":"crossref","first-page":"316321","DOI":"10.1007\/BF00265549","article-title":"Effect of nicotinamide treatment on the residual insulin secretion in type 1 (insulindependent) diabetic patients.","volume":"32","author":"Vague","year":"1989","journal-title":"Diabetologia"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23639","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201007000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:05:02Z","timestamp":1741777502000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201007000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23639","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}